Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease

This study has been completed.
Sponsor:
Collaborator:
Glaxo Wellcome
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00000662
First received: November 2, 1999
Last updated: October 27, 2016
Last verified: April 1992
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 1993
  Primary Completion Date: May 1993 (Final data collection date for primary outcome measure)